Stopped: Patients were selected but their very condition and the resulting comorbidities did not allow their inclusion. In addition, the health crisis prevented any bariatric operation of this complexity for an indefinite period.
This study aims to assess safety and efficacy of bariatric embolization of the gastro-epiploic arcade using 300-500 micrometres calibrated polyvinyl-alcohol microparticles, for patients with morbid obesity.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with adverse events
Timeframe: 7 days post embolization
Number of participants with adverse events
Timeframe: 1 month post embolization
Number of participants with adverse events
Timeframe: 3 months post embolization
Number of participants with adverse events
Timeframe: 6 months post embolization
Number of participants with adverse events
Timeframe: 12 months post embolization